Prednisone may improve effectiveness of AAV-based gene therapy by reducing immune response

(Mary Ann Liebert, Inc./Genetic Engineering News) A new study of gene transfer using adeno-associated virus (AAV)-based gene delivery into skeletal muscle of rhesus macaques showed that oral prednisone reduced immune responses to AAV that can weaken expression of the therapeutic transgene over time.